Newsletter

Back to overview
Newsletters

icIEF Updates: services, kits, publications and more!

icIEF Platform for FDA regulations: What you see is what you collect

Does the fraction represent the icIEF-identified variant? Our High Yield Fractionation icIEF-Prep responds this with scientific certainty. For the first time, focused charge isoforms can be directly eluted from the separation capillary through nano-flow mobilization control.

  • Direct collection of the icIEF peaks of interest.
  • No need for indirect orthogonal platforms.
  • No more uncertainty surrounding the identity of preparative fractions.
  • Unequivocal correlation: “It is what it is.” vs. the assumption-based validation pI comparison e.g. IEX.

 icIEF Platform for FDA regulations: What you see is what you collect

Contact us

Secure Your Method Development — AESlyes as Backup Plan

Are you developing a new method? Make sure to have a backup plan in case you don’t get your Pharmalyte or Servalyte delivered.

  • If you wish to learn more visit our website
  • We are happy to consult you with making the right choice. Book an appointment with us for further support. 

Contact us

NEW Publication: icIEF technology for in-depth biopharmaceutical characterization

Key icIEF user

"We thank Dr. David A. Michels and Dr. Feng Yang from Genentech, Dr. Bo Yan from Beam Therapeutics and Professor Janusz Pawliszyn from University of Waterloo for sharing their great experiences and sharing their great insights on the use of the Traditional icIEF and our Next Generation icIEF Solutions" - Isogen Life Science Team. 

Key learnings:

  • Redefine icIEF Analytical methodologies broadening their applications:
    • Critical reagents.
    • Capillary coatings for advanced icIEF fractionation.
    • Cutting-edge icIEF-MS online coupling.
    • Novel applications for protein bio-interactions.
  • How to mitigate challenges and setbacks during drug development: icIEF characterizes complex therapeutic proteins.
  • Book an appointment with us for further support

Download the publication

Tao Bo, et al. (2025). "Recent Development of icIEF technology for in-depth biopharmaceutical characterization. Trends in Analytical Chemistry 187

New! Minimise the use of additives with our dedicated icIEF Assay Kits

Our new icIEF assay kits are based on reliable hydrophobic cross-linked silicone coating cartridge.

Contact us for any inquiries

New! Avidity Characterization Services for Antibody Engineering

Cell-antibody avidity matters in Antibody Engineering: We help you to improve your drug development process by determining the potency and specificity of the validated target.

  • Select the right antibody for targeting cells in pre-clinical research.
  • Compatible with different cell lines, including cancer cells.
  • Accelerate IND (Investigational New Drug) applications.
  • Enhancing the Likelihood of Approval (LOA) in clinical trials.

 

Back to overview